Lachnoclostridium intestinal flora is associated with immunotherapy efficacy in nasopharyngeal carcinoma

Documents similaires

• Evaluating the reduction of elective radiotherapy fields for de novo metastatic nasopharyngeal carcinoma in the immunotherapy era
  par: Ting Jin, et autres
  Publié: (2024)
• Loco‐regional radiotherapy in de novo metastatic nasopharyngeal carcinoma with chemotherapy and immunotherapy: A real‐world retrospective study from two cancer centers
  par: Li Ma, et autres
  Publié: (2024)
• Mecapegfilgrastim for the prophylaxis of chemotherapy‐induced neutropenia in locally advanced nasopharyngeal carcinoma: A prospective phase II clinical study
  par: Qifeng Jin, et autres
  Publié: (2024)
• Predicting the overall survival and progression‐free survival of nasopharyngeal carcinoma patients based on hemoglobin, albumin, and globulin ratio and classical clinicopathological parameters
  par: Zui Chen, et autres
  Publié: (2024)
• Clinical characteristics and prognostic factors in nasopharyngeal carcinoma with brain metastasis: A retrospective, single‐center study
  par: Nan Huang, et autres
  Publié: (2024)